Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Adaptive Biotechnologies Corporation”

5 pharma patents match "Adaptive Biotechnologies Corporation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "Adaptive Biotechnologies Corporation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “Adaptive Biotechnologies Corporation” · 30,257 patents in full index Clear search

  1. US 12263179

    Lyme disease-associated T cell receptor-related methods

    Adaptive Biotechnologies Corporation · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  2. US 12266425

    T cell receptor sequences diagnostic for COVID-19 and related compositions

    Adaptive Biotechnologies Corporation · Granted Apr 1, 2025 · Expires Mar 27, 2045

    granted
  3. US 11390921

    Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)

    Adaptive Biotechnologies Corporation · Granted Jul 19, 2022 · Expires Jul 14, 2042

    granted
  4. US 11041202

    Method of identifying human compatible T cell receptors specific for an antigenic target

    Adaptive Biotechnologies Corporation · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  5. US 11026969

    High affinity T cell receptors and uses thereof

    Adaptive Biotechnologies Corporation · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted